Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy

The Superior Health Council of Belgium reviewed its recommendations concerning the administration of the “COVID-19 Vaccine AstraZeneca ® ” vaccine on the basis of the most recent knowledge and scientific data. This report aims at providing the Belgian Immunization Strategy and Operationalization Taskforce and general practitioners with a risk analysis of non-replicative viral vector vaccines for vaccination against COVID-19 in Belgium and provides specific recommendations on strategic COVID-19 vaccination in Belgium.